Viewing StudyNCT05882058



Ignite Creation Date: 2024-05-06 @ 7:05 PM
Last Modification Date: 2024-10-26 @ 2:59 PM
Study NCT ID: NCT05882058
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-03
First Post: 2023-05-22

Brief Title: DAREON-5 A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-09-25
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-25
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-07-03
Completion Date Type: ESTIMATED
First Submit Date: 2023-05-22
First Submit QC Date: May 22 2023
Study First Post Date: 2023-05-31
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-14
Last Update Post Date: 2024-06-03
Last Update Post Date Type: ACTUAL